Key Takeaways
- • KKR is in advanced talks to acquire Sweden-based Medicover's 66.9% majority stake in Medicover Hospitals India for at least $1 billion, marking a significant expansion of the private equity firm's healthcare footprint in India.
- • Medicover Hospitals India operates a network of 26 hospitals with approximately 6,000 beds and entered the Indian market in 2016; KKR is also in discussions with minority shareholders to acquire their remaining stake in the business unit.
- • A non-binding agreement has been reached between the parties, with discussions described as ongoing; Medicover simultaneously confirmed the negotiations while stating no certainty exists that talks will result in a completed transaction.
- • The deal would represent KKR's continued strategic bet on India's healthcare sector, as the firm has been steadily increasing healthcare investments across the country in recent years.
- • Medicover is proceeding in parallel with preparations for an Indian initial public offering, reserving strategic optionality as it evaluates the KKR sale process.
Summary
KKR is pursuing a majority stake acquisition in Medicover Hospitals India, the Indian subsidiary of Stockholm-listed Swedish healthcare operator Medicover, in a transaction valued at a minimum of $1 billion. According to Reuters, KKR is in advanced talks to acquire Medicover's 66.9% stake for at least $1.05 billion and is simultaneously negotiating with minority shareholders to secure full ownership of the Indian operations.
Medicover Hospitals India represents a meaningful healthcare platform, having expanded its footprint across the country since entering the market in 2016. The company currently operates 26 hospitals with approximately 6,000 beds, positioning it as a significant player within India's fragmented hospital sector. The transaction would mark a notable addition to KKR's growing healthcare portfolio in India, where the firm has been systematically increasing its investment exposure.
According to sources with direct knowledge of the negotiations, a non-binding agreement has been reached between KKR and Medicover, with discussions remaining active. Medicover's Stockholm-listed parent company issued a press release on June 18, 2026, confirming that Medicover Hospitals India is "in discussions with KKR regarding a potential sale of its Indian operations." The company declined to provide transaction specifics and emphasized that discussions carry no certainty of completion.
Notably, Medicover is maintaining strategic flexibility by simultaneously advancing preparations for an Indian initial public offering. The company stated it will continue pursuing the IPO process alongside the KKR negotiations, preserving multiple exit pathways as it evaluates its options for the Indian business unit. This parallel process suggests ongoing optionality regarding the ultimate capital structure and ownership of the hospital network.
Medicover Hospitals India represents a meaningful healthcare platform, having expanded its footprint across the country since entering the market in 2016. The company currently operates 26 hospitals with approximately 6,000 beds, positioning it as a significant player within India's fragmented hospital sector. The transaction would mark a notable addition to KKR's growing healthcare portfolio in India, where the firm has been systematically increasing its investment exposure.
According to sources with direct knowledge of the negotiations, a non-binding agreement has been reached between KKR and Medicover, with discussions remaining active. Medicover's Stockholm-listed parent company issued a press release on June 18, 2026, confirming that Medicover Hospitals India is "in discussions with KKR regarding a potential sale of its Indian operations." The company declined to provide transaction specifics and emphasized that discussions carry no certainty of completion.
Notably, Medicover is maintaining strategic flexibility by simultaneously advancing preparations for an Indian initial public offering. The company stated it will continue pursuing the IPO process alongside the KKR negotiations, preserving multiple exit pathways as it evaluates its options for the Indian business unit. This parallel process suggests ongoing optionality regarding the ultimate capital structure and ownership of the hospital network.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.